Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Glaucoma Surgery Devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Glaucoma Surgery Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Glaucoma Surgery Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Glaucoma Surgery Devices Overview
3 Products under Development
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials
4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
5 Glaucoma Surgery Devices Companies and Product Overview
6 Glaucoma Surgery Devices- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Pipeline Products by Segment
Glaucoma Surgery Devices - Pipeline Products by Territory
Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Glaucoma Surgery Devices - Ongoing Clinical Trials
Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Ciliatech Therapeutics AG - Ongoing Clinical Trials Overview
Cilio-Scleral Inter-Positioning Device (CID) - Monocentre, Observational Clinical Study Evaluating the Efficacy and Safety of a Novel Interposition Supraciliary Implant in Glaucoma Surgery
Cilio-Scleral Inter-Positioning Device (CID) - Multicentre, Non-randomised Clinical Study Evaluating the Efficacy and Safety of Cilioscleral Interposition Device v2.2 in Glaucoma Surgery
Cilio-Scleral Inter-Positioning Device (CID) - Non Randomised Mono-centered Study to Evaluate Safety and Efficacy of a Novel Cilioscleral Interposition Device (CID) SV22 in Glaucoma Patients Refractory to Topical Therapy
iStent Infinite Trabecular Micro-Bypass System - Product Status
iStent Infinite Trabecular Micro-Bypass System - Product Description
Glaukos Corp - Ongoing Clinical Trials Overview
iStent Infinite Trabecular Micro-Bypass System - A Prospective, Multicenter Study of the Glaukos iStent Infinite Trabecular Micro-Bypass System Model iS3 in Subjects with Mild to Moderate Primary Open-angle Glaucoma
iStent Infinite Trabecular Micro-Bypass System - A Prospective, Randomized, Controlled, Comparative Multicenter Clinical Study of Glaukos Trabecular Micro-Bypass System Model iS3 Infinite Vs. Hydrus in Adult Subjects with Primary Open-Angle Glaucoma (POAG)
Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
CycloPen Cyclodialysis System - Product Description
Iantrek Inc - Ongoing Clinical Trials Overview
CycloPen Cyclodialysis System - An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen Micro-Interventional Cyclodialysis System Procedures in Patients with Open Angle Glaucoma
PreserFlo MicroShunt - Evaluation of Minimal Invasive Glaucoma Surgery: Trabeculectomy Vs. Xen Vs. Preserflo Randomized Clinial Trial
PreserFlo MicroShunt - SIGHT study: Cost-effectiveness of InnFocus Microshunt (IMS) Implantation Versus Standard Trabeculectomy (TE)
PreserFlo MicroShunt - Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation - a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt
iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
MINIject - Product Status
MINIject - Product Description
STARflo MINI - Product Status
STARflo MINI - Product Description
STARflo Plus Glaucoma Implant - Product Status
STARflo Plus Glaucoma Implant - Product Description
iSTAR Medical SA - Ongoing Clinical Trials Overview
MINIject - A Prospective, Open, Multicenter Clinical Trial Evaluating the Efficacy and Safety of MINIject Combined with Cataract Surgery in Patients with POAG Uncontrolled by Topical Hypotensive Medications and Operable Age-related Cataract Diagnosis
MINIject - A Prospective, Open, Multicenter Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
MINIject - Evaluate the Safety and Effectiveness of ISTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects with Primary Open-angle Glaucoma.
MINIject - STAR-LIFE: A Post-market Registry on MINIject
Vivid White Pty Ltd - Ongoing Clinical Trials Overview
VividFlo Glaucoma Implant (VW-51) - A Prospective Multicentre Pivotal Clinical Study to Demonstrate the Efficacy and Safety of the VividWhite Glaucoma Implant (VW-51) for the Treatment of Glaucoma.